Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Short term Debt: 2013-2024

Historic Short term Debt for Rockwell Medical (RMTI) over the last 8 years, with Dec 2024 value amounting to $2.4 million.

  • Rockwell Medical's Short term Debt fell 20.84% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 20.84%. This contributed to the annual value of $2.4 million for FY2024, which is 5.16% down from last year.
  • Latest data reveals that Rockwell Medical reported Short term Debt of $2.4 million as of FY2024, which was down 5.16% from $2.5 million recorded in FY2023.
  • In the past 5 years, Rockwell Medical's Short term Debt ranged from a high of $7.4 million in FY2021 and a low of $131,000 during FY2020.
  • For the 3-year period, Rockwell Medical's Short term Debt averaged around $2.2 million, with its median value being $2.4 million (2024).
  • Its Short term Debt has fluctuated over the past 5 years, first surged by 5,534.35% in 2021, then plummeted by 77.90% in 2022.
  • Over the past 5 years, Rockwell Medical's Short term Debt (MRY) stood at $131,000 in 2020, then soared by 5,534.35% to $7.4 million in 2021, then tumbled by 77.90% to $1.6 million in 2022, then soared by 53.28% to $2.5 million in 2023, then decreased by 5.16% to $2.4 million in 2024.
  • Its Short term Debt was $2.4 million in FY2024, compared to $2.5 million in FY2023 and $1.6 million in FY2022.